Novavax Stock Down On Concern Over Whether The Company Can Continue
Image Source: Unsplash
CNBC’s Meg Tirrell joins ‘Closing Bell: Overtime’ to report on Novavax’s (NVAX) warning that it may not be able to continue as a company. Also, Sarepta (SRPT) shares rise on FDA signaling no advisory meeting on gene therapy.
Video Length: 00:03:15
More By This Author:
Warner Bros. Discovery Misses On Revenue
Coca-Cola CEO James Quincey On Q4 Earnings: We Had A Good Finish To The Year
PepsiCo CFO Hugh Johnston: Inflation Didn’t Moderate At All During Q4
How did you like this article? Let us know so we can better customize your reading experience.
Comments
No Thumbs up yet!
